Full text 
Procedure : 2018/2775(RSP)
Document stages in plenary
Document selected : B8-0071/2019

Texts tabled :


Debates :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Votes :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Explanations of votes

Texts adopted :


Verbatim report of proceedings
Wednesday, 13 February 2019 - Strasbourg Revised edition

16.11. Use of cannabis for medicinal purposes (B8-0071/2019) (vote)
Video of the speeches

- Prima della votazione sull'emendamento 11:


  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.


  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.


(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

Last updated: 24 May 2019Legal notice - Privacy policy